CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 1,988.80
-15.30 (-0.76%)
At close: Jul 7, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 121.64 billion as of July 7, 2026.
Market Cap
121.64B
Enterprise Value
123.00B
Revenue
14.03B
Ranking
n/a
PE Ratio
65.71
Stock Price
1,988.80
Market Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 121.64B, an increase of 38.26%. That is a compound annual growth rate of 78.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 121.64B | 43.61% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 379.44B |
| Rubicon Research | 215.33B |
| AstraZeneca Pharma India | 207.45B |
| Granules India | 206.45B |
| Caplin Point Laboratories | 192.72B |
| Jubilant Pharmova | 153.45B |
| Viyash Scientific | 128.41B |
| Procter & Gamble Health | 105.60B |